Ivo Lorenz is the Head of Biologics at Deerfield Discovery and Development in New York. A native of Switzerland, he obtained his PhD in Biochemistry from the Swiss Federal Institute of Technology. After his postdoctoral training at The Rockefeller University, Dr. Lorenz held group leader positions at the International AIDS Vaccine Initiative and at Boehringer Ingelheim Pharmaceuticals, where he gained extensive experience in biologics drug discovery and project management. He then established and led the biologics discovery team in his role as Vice President, Biologics at the Tri-Institutional Therapeutics Discovery Institute, an academic drug discovery center jointly run by Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine in New York. At Deerfield, Dr. Lorenz and his team work on a pipeline of biologics discovery and development programs to find new, innovative medicines for a variety of diseases, and advance them to the clinic.